US 10,555,939 B2
Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
Log In
Please sign up or log in to access the advanced features of
Ex Parte Enterprise.
or Log in

General

US 10,555,939 B2
Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
Alma Pipic
Art Unit:
1617 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
Agent:
Jones Day
Inventors:
Anthony J. Tutino; Michael T. Kelly
Assignee:
CELGENE CORPORATION
Priority:
05/19/09
Filed:
05/10/18
Granted:
02/11/20
Expiration:
05/19/29
Abstract
Pharmaceutical compositions and single unit dosage forms of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione, or a pharmaceutically acceptable stereoisomer, prodrug, salt, solvate, hydrate, or clathrate, are provided herein. Also provided are methods of treating, managing, or preventing various disorders, such as cancer or an inflammatory disease.
Cooperative Patent Classification (CPC)
A61A61K9/4858A61P11/00A61KY02A50/30Y02A

Analytics

Cases

Patent Assignments

Citations